Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...

British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...

Within financials ( XLF ), Wald mentioned capital markets and the SPDR S&P Capital Markets ETF ( KCE) as a top idea, ...

Amid the financial shock waves being sent by the release of DeepSeek's open source artificial intelligence R1 model, ...

Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Christopher Nolan has recently announced his reunion with Oppenheimer star Benny Safdie for his next movie.Safdie, who appeared as physicist Edward Teller in Nolan’s Oscar-winning movie, ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.

Fintel reports that on January 29, 2025, Oppenheimer downgraded their outlook for Transcat (NasdaqGM:TRNS) from Outperform to ...

Christopher Nolan has added another star who appeared in Oppenheimer to his mythic adventure The Odyssey. Benny Safdie, who portrayed Edward Teller, recently joined the bandwagon, according to The ...

Following their successful collaboration on ‘Oppenheimer’, director Christopher Nolan has again reunited with actor Benny Safdie for his next major project, ‘The Odyssey’. Safdie, known for his work ...

Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...